Race‐specific prostate cancer outcomes in a cohort of low and favorable‐intermediate risk patients who underwent external beam radiation therapy from 1990 to 2017

MLA

Sean P. Stroup, et al. “Race‐specific Prostate Cancer Outcomes in a Cohort of Low and Favorable‐intermediate Risk Patients Who Underwent External Beam Radiation Therapy from 1990 to 2017.” Cancer Medicine, vol. 11, no. 24, Dec. 2022, pp. 4756–66. EBSCOhost, https://doi.org/10.1002/cam4.4802.

APA

Sean P. Stroup, Audry H. Robertson, Kayla C. Onofaro, Michael G. Santomauro, Nicholas R. Rocco, Huai‐ching Kuo, Avinash R. Chaurasia, Samantha Streicher, Darryl Nousome, Timothy C. Brand, John E. Musser, Christopher R. Porter, Inger L. Rosner, Gregory T. Chesnut, Anthony D’Amico, Grace Lu‐Yao, & Jennifer Cullen. (2022). Race‐specific prostate cancer outcomes in a cohort of low and favorable‐intermediate risk patients who underwent external beam radiation therapy from 1990 to 2017. Cancer Medicine, 11(24), 4756–4766. https://doi.org/10.1002/cam4.4802

Chicago

Sean P. Stroup, Audry H. Robertson, Kayla C. Onofaro, Michael G. Santomauro, Nicholas R. Rocco, Huai‐ching Kuo, Avinash R. Chaurasia, et al. 2022. “Race‐specific Prostate Cancer Outcomes in a Cohort of Low and Favorable‐intermediate Risk Patients Who Underwent External Beam Radiation Therapy from 1990 to 2017.” Cancer Medicine 11 (24): 4756–66. doi:10.1002/cam4.4802.